Human Medicine:

BLADDER CANCER

Bladder cancer is where a growth of abnormal tissue, known as a tumour, develops in the bladder lining. In some cases the tumour spreads into the bladder muscle. The bladder is part of the urinary system, which includes all of the organs that create and pass urine. The most common symptom of bladder cancer is blood in your urine, which is usually painless.

BLADDER CANCER TESTING

SYNLAB works closely with clinics and urologists to provide a non-invasive bladder cancer diagnostic test, ADXBLADDER. Click here for further information on ADXBLADDER.

Any patients interested in bladder cancer testing should contact their clinic / urologist.

BLADDER CANCER SYMPTOMS

  • Blood in urine
  • Need to urinate more frequently
  • Pain when urinating
  • Kidney pain

BLADDER CANCER FACTS

  • Around 10,200 people are diagnosed with bladder cancer in the UK every year.
  • Bladder cancer is the 10th most common cancer in the UK, and the 8th most common cancer in men.
  • Bladder cancer usually takes a long time to develop, so it is most common in older people.
  • Almost 60% of new cases are in people aged 75+.
  • Bladder cancer is rare in people aged under 40.
  • More men than women get bladder cancer.

Source: Cancer Research UK

More information about bladder cancer can be found at: https://www.cancerresearchuk.org/about-cancer/bladder-cancer

Latest Human Medicine News
SYNLAB Announce Agreement with Arquer Diagnostics for Bladder Cancer Testing

13 July 2020 SYNLAB UK & Ireland and Arquer Diagnostics, a UK-based company committed to manufacturing and marketing innovative, non-invasive tests for diagnosing and monitoring…

Read More (about 'SYNLAB Announce Agreement with Arquer Diagnostics for Bladder Cancer Testing')
SYNLAB Laboratory Services Maintains ISO 15189:2012 UKAS Accreditation

7th April 2020 – SYNLAB Laboratory Services, part of Europe’s leading medical diagnostics provider SYNLAB Group, is pleased to announce that the company has successfully…

Read More (about 'SYNLAB Laboratory Services Maintains ISO 15189:2012 UKAS Accreditation')
Press Statement: SYNLAB UK & Ireland Confirmed as Preferred NHS Strategic Partner

21 January 2020 SYNLAB UK & Ireland has been confirmed as the preferred strategic partner to transform and deliver NHS pathology services in South East London. SYNLAB…

Read More (about 'Press Statement: SYNLAB UK & Ireland Confirmed as Preferred NHS Strategic Partner')